CAS: 39684-28-1; O-(Tert-Butyl)Hydroxylamine Hydrochloride

该化合物是一种稳定,固体的氢氟烷衍生物,广泛用作有机合成和制药应用中的多用途试剂,其三丁基乙基氨基混合物与非代用氢氧基胺相比,加强了消毒保护,稳定性和处理能力.氢氯丁基盐形式确保极地溶剂溶解性,促进硝化物形成,氧化和核循环添加等反应.这种化合物在氮氧化物合成和聚合物化学中作为激进的采集剂特别宝贵.其一贯的纯度和可靠性能使得在温度条件下需要受控的氢氧化胺再活性的研究者更愿意选择这种化合物.

结构式图片

相似化合物

4490-81-7 6084-58-8 3332-29-4

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号51951-30-5 N-(tert-butoxy)... | CAS号326801-14-3 Methyl 2-fluoro... | CAS号455-68-5 3-氟苯甲酸甲酯 | CAS号292618-32-7 ST1481 | CAS号608520-17-8 ethyl 3-[(2-met...

合成工艺路线路线简述

    Ethyl O-Tert-Butylacetohydroxamate置于盐酸体系中,用 水 作为反应溶剂,化学反应 2.5H,以88.5%的收率获得产物o-叔丁基羟胺盐酸盐
    参考文献:O-取代羟胺盐酸盐及其制备方法
    标题:O-取代羟胺盐酸盐及其制备方法
    摘要:本发明提供一种o‑取代羟胺盐酸盐及其制备方法,其中,制备方法包括如下步骤:步骤s1,向乙酰羟肟酸乙酯的乙醇溶液中加氢氧化钠,此外同时滴加卤代烃,磺酰氯或酰氯以发生取代反应,此后加到水中以析出o‑取代乙酰羟肟酸乙酯;步骤s2,将所述o‑取代乙酰羟肟酸乙酯加入盐酸溶液中回流反应以反应生成o‑取代羟胺盐酸盐.根据本发明实施例的o‑取代羟胺盐酸盐的制备方法,能够得到纯度高的产品,且该方法安全,易处理,工艺简单,适合工业化生产.

    海关参考信息

    专利信息


    专利号:WO-2023225524-A1
    优先权日:2022-05-17
    标题:Preparation of highly concentrated mrna
    发明人:GENG MARK; SINOIMERI JAMES
    权利人:MODERNATX INC
    摘要:Provided herein are compositions of highly concentrated mRNA and related methods for preparation and use of the compositions as mRNA process intermediates in the synthesis of therapeutic and prophylactic mRNA formulations.

    专利号:WO-2013010573-A1
    优先权日:2011-07-18
    标 题:Compounds with matrix-metalloproteinase inhibitory activity
    发明人:HAUFE GUENTER; KOPKA KLAUS; WAGNER STEFAN; HUGENBERG VERENA; HERMANN SVEN; SCHAEFERS MICHAEL; KOLB HARTMUTH
    权利人:UNIV MUENSTER; SIEMENS MEDICAL SOLUTIONS; HAUFE GUENTER; KOPKA KLAUS; WAGNER STEFAN; HUGENBERG VERENA; HERMANN SVEN; SCHAEFERS MICHAEL; KOLB HARTMUTH
    摘要:The present invention relates to the field of therapeutic and diagnostic agents and more specifically to compounds of formula (I) that are inhibitors of matrix-metalloproteinases (MMPs) and are useful in the treatment of diseases related thereto such as cardiovascular diseases, inflammatory diseases and malignant diseases. One embodiment of the invention is a compound of formula (I) labeled with a 18-fluorine atom having matrix metalloproteinase inhibitory activity suitable for diagnostic imaging. Also disclosed in the present invention is a pharmaceutical composition comprising the inhibitors of matrix-metalloproteinases (MMPs) of the invention or the corresponding labeled compounds useful as diagnostic imaging agents of the invention in a form suitable for mammalian administration. The invention furthermore discloses intermediates in the synthesis of the inhibitors of matrix-metalloproteinases (MMPs) of the invention and of the diagnostic imaging agents of the invention.

    专利号:US-6512143-B1
    优先权日:1998-07-10
    标 题:Salts of N-tert-butylhydroxylamine
    发明人:BLIXT JOERGEN
    权利人:ASTRAZENECA AB
    摘要:Novel salts of N-tert-butylhydroxylamine with lower carboxylic acids are disclosed, together with processes for their preparation. The salts possess advantageous properties that render them useful in synthesis.

    专利号:US-5510511-A
    优先权日:1992-01-14
    标 题 :Process for preparing N,O-dialkylhydroxylamine, its salts or intermediates in their synthesis
    发明人:INOKI SATOSHI; TAKESUE MITSUYUKI; HASHIMOTO ISAO; KIHARA NORIAKI; SUGI KIYOAKI
    权利人:MITSUI PETROCHEMICAL IND
    摘要:A process for preparing N,O-dialkylhydroxycarbamic acid ester which comprises reacting hydroxylamine or its salt with dihydrocarbyl carbonate in the presence of a basic compound to prepare hydroxycarbamic acid ester and subsequently alkylating this compound with an alkylating agent; a process for recovering N,O-dialkylhydroxycarbamic acid ester which comprises azeotropically distilling the ester with water from a solution containing the ester; a process for preparing N,O-dialkylhydroxylamine which comprises hydrolyzing N,O-dialkylhydroxycarbamic acid ester in an aqueous solution or a hydrous solvent in the presence of an alkali; a process for purifying N,O-dialkylhydroxylamine hydrochloride which comprises adding aldehyde or ketone to a solution of N,O-dialkylhydroxylamine hydrochloride containing O-alkylhydroxylamine hydrochloride as impurities to convert the O-alkylhydroxylamine hydrochloride into O-alkyl aldoxime or O-alkyl ketoxime and subsequently separating the N,O-dialkylhydroxylamine hydrochloride from the reaction system; and a process for separating N,O-dialkylhydroxylamine hydrochloride which comprises (i) adding benzene or alkylated benzene to an aqueous solution containing N,O-dialkylhydroxylamine hydrochloride, azeotropically removing water or a hydrochloride solution, and, subsequently (ii)adding alcohol thereto to obtain N,O-dialkylhydroxylamine hydrochloride in the form of crystal.

    专利号:MX-PA04003330-A
    优先权日:2001-10-09
    标题 :4- (2-FUROIL) NOVEDOUS AMINOPIPERIDINS, INTERMEDIATE COMPOUNDS IN THE SYNTHESIS OF THE SAME, PROCESS FOR PRODUCERS AND THEIR MEDICINAL USE.

    专利号:RU-2172316-C2
    优先权日:1994-12-07
    标题 :Rapamycin 42-oximes and hydroxylamines, method of synthesis, intermediate compounds, pharmaceutical composition and method of treatment of patient
    郑州今斯孚化学有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.kingsfine.com/index.html
    电话: 0371-56632527 13838252817👤
    📞郑州今斯孚化学有限公司 ⚠️参考联系方式

    销售电话:0371-56632527 13838252817
    邮箱:sales@kingsfine.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: Klaus Kopka, Et Al. Synthesis And Preliminary Biological Evaluation Of New Radioiodinated Mmp Inhibitors For Imaging Mmp Activity In Vivo. Nucl Med Biol. 2004 Feb;31(2):257-67.

    合成参考文献

    合成方法参考DOI号:10.1016/j.tetlet.2005.07.149
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知